Recent advances in endoscopic submucosal dissection (ESD) techniques contribute to endoscopic treatment of early gastric cancer (EGC). Recognition of chronic atrophic gastritis as the background is important for high-quality detection and diagnosis of EGC. But, relationships between EGC and atrophy of the background gastric mucosa caused by Helicobacter pylori are not well understood. The present study demonstrated histopathological phenotypes of EGC, as well as chronic atrophic gastritis as background mucosa of EGC. We evaluated mucosal heights, number of glands, and degree of intestinal metaplasia (IM) of the background gastric mucosa, using 81 cases of EGC resected by ESD. Gastric phenotype cancer cases showed IM of the background gastric mucosa less frequently, compared with intestinal phenotype cancer cases (score of IM, 1.15 vs. 1.65, P = 0.012). The average mucosal heights around EGC were lower in moderately to poorly differentiated adenocarcinoma cases than well differentiated adenocarcinoma cases (442.6 μm vs. 500.2 μm, P = 0.011). The mucosal atrophy indicated by average heights of background mucosa was low in the gastric phenotype cancer cases, compared with the intestinal phenotype cancer cases (452.8 μm vs. 505.6 μm, P = 0.018). In the fundic gland area, the mucosal heights were low in the gastric phenotype cancer cases, compared with the intestinal phenotype cancer cases (413.2 μm vs. 495.5 μm, P = 0.015). Our results using EGC specimens indicated that gastric phenotype cancer and moderately to poorly differentiated adenocarcinoma had atrophic background mucosa with lower mucosal heights and less IM. The atrophic gastric mucosa with less IM is thought to play an important role in gastric carcinogenesis, especially tumoriogenesis of gastricphenotype cancer.
Recently, due to advances in techniques for diagnosing gastric cancer, such as endoscopy and development of narrow band imaging (NBI), the number of patients diagnosed with early gastric cancer (EGC) has been increased both in Japan and elsewhere (8, 12, 14) . It is very important to detect EGC and to make its preoperative diagnosis, because endoscopic therapy or surgical treatment after the early detection can result in better prognosis of gastric cancer (14) . In the field of endoscopic therapy, endoscopic mucosal resection (EMR) focuses on only smallsized EGC, but advances in endoscopic submucosal dissection (ESD) are able to treat large EGC. EGC is histopathologically classified into two types, i.e. "intestinal type" composed of well differentiated adenocarcinoma, and "diffuse type" composed of undifferentiated carcinoma (actually poorly differentiated adenocarcinoma and/or signet-ring cell carcinoma), based on the tendency of gland formation (7, histochemical staining.
Histopathological and immunohistochemical examinations.
Immunohistochemical examination was performed on deparaffinized sections using the standard avidin-biotin-peroxidase complex (ABC) method with an automated immunostainer (Benchmark XT; Ventana Medical System, Tucson, AZ, USA). The antibodies used are listed in Table 2 . Both cytoplasmic and luminal membranous immunoreactivities were judged as positive for human gastric mucin (HGM) and CD10, and cytoplasmic immunoreactivity as positive for MUC5AC, MUC6 and MUC2. HGM, MUC5AC, MUC6 and MUC2 are extracellular secreted mucins. The mucins are high-molecular weight glycoproteins and widely distributed in areodigestive and genital organs, and are associated with cell-to-cell adhesion, cell migration including tumor metastasis, and immunological defense. CD10 is expressed on the surface of a variety of normal and neoplastic cells, and is highly detected on immature B lympocytes, intestinal brush borders, and renal epithelial cells. CD10 is reactive predominantly at the cell membrane, while the mucins react predominantly in the cytoplasm. CDX2, a caudal-related homeobox gene, is a regulatory factor for intestinal development and differentiation of goblet cells. Increased CDX2 expression is seen in intestinal type cancers, and may play a role in gastric carcinogenesis. 11, 20) . The "intestinal type" tumors have been considered to arise from gastric mucosa with intestinal metaplasia (IM) and the "diffuse type" tumors from gastric mucosa without IM. It has been suggested that these two tumor types involve distinct pathways of the gastric carcinogenesis (19, 20, 23) . Chronic atrophic gastritis is caused mainly by Helicobacter pylori infection. Gastric mucosal atrophy defined as loss of mucosal glands leads to thinning of the mucosa, and is a common denominator in all pathological processes, causing severe mucosal damage. In addition, IM is common in chronic gastritis infected with Helicobacter pylori. Therefore, scoring of the Updated Sydney System includes the mucosal atrophy and IM, in addition to inflammatory cell infiltration (2) . The risk of developing gastric cancer is related to chronic active inflammation with Helicobacter pylori (17, 22) . Previous studies have suggested that some types of IM provide important information regarding the risks of gastric cancer (15) . IM is thought to be one of the precancerous lesions in the multiple progression of gastric carcinoma as proposed by Correa (1) . However, the relationship of EGC and atrophic mucosa without IM are not well understood. In this study, we evaluated gastric atrophy using mucosal heights, number of glands and score of IM, and relationships between EGC and its background atrophic mucosa.
MATERIALS AND METHODS
Patient materials and tissue sampling. We analyzed 81 EGC cases resected by endoscopic submucosal resection (ESD) and filed in Hirosaki University Hospital and Seihoku Chuo Hospital. The clinicopathological data of the cases are summarized in Table 1. The histological classification is based on the Japanese Classification of Gastric Carcinoma (4). EGC tissue specimens resected by ESD were pasted on the cork boards on equal force stretched, routinely fixed with 10% buffered formalin and examined carefully at macroscopic levels. These specimens were serially cut in 2 mm-width, embedded in paraffin, thin-sectioned, and stained with hematoxylin and eosin (H&E). After examination of the H&E sections, histological mapping of the cancer tissue was performed on color prints. Several representative tissue sections in each case were selected for histochemistry and immunohistochemistry of mucin phenotypic analysis. Paraffin blocks corresponding to the selected H&E sections were cut into 4 μm consecutive sections for histochemical and immuno- phenotypes and histopathological grades was analyzed using the Pearson χ 2 test. The nonparametric Mann-Whitney U-test was used to compare average of mucosal heights, number of glands and presence of IM with clinical characteristics. The P values were two-sided, and P values of < 0.05 were considered statistically significant. We used SPSS software, version 12.0 (SPSS, Inc., Chicago, IL, USA). (Fig. 2) .
RESULTS

Mucin phenotypes in gastric cancers
Evaluation of background atrophic mucosa. To investigate the relationship between early gastric cancer and the background of non-neoplastic mucosa, we evaluated three indicators of background mucosa: (a) mucosal heights, (b) the number of glands per 100 times power field and (c) the presence of intestinal metaplasia (IM) (Figs. 1A and 2A) . The mucosal heights were evaluated as the average of three points which we measured in each lesion, i.e. EGC lesion and its background non-neoplastic mucosa. The evaluation of IM was according to the Updated Sydney System scores 0-3, i.e., 0, none; 1, mild; 2, moderate; and 3, severe IM (2). Table 3) .
Statistical analysis. The correlation between mucin
Relationship between mucin phenotypes of gastric cancer and its the background mucosa
We measured the mucosal heights and the number of glands, and evaluated the scores of IM of the non-neoplastic gastric mucosa around EGC. The average scores of IM of the background mucosa were lower in score of IM (1.15 of IM score) than that of intestinal type group (1.65 of IM score, P = 0.012).
Of the 81 cases, 41 EGC cases (50.6%) were located to the fundic gland area, 38 cases (46.9%) in the pyloric gland area, and the other two cases (2.5%) were in the cardiac gland area. In the fundic gland area, there was a tendency that the average mucosal heights around EGC were lower in moderately to poorly differentiated adenocarcinoma cases (428.9 μm) than in well differentiated adenocarcinoma cases (484.4 μm, P = 0.075) ( Table 4 ). The average scores of IM was significantly lower in moderately to poorly differentiated adenocarcinoma cases (1.29 of IM score) than in well differentiated adenocarcinoma cases (2.00, P = 0.010). Based on the mucin phenotypes of EGC, the average mucosal heights around EGC were lower in the gastric type group (413.2 μm) than that in intestinal type group (495.5 μm, P = 0.015).
In the pyloric gland area, there was a tendency that the average mucosal heights around EGC were lower in moderately to poorly differentiated adenocarcinoma cases, as well as in the gastric phenotype group (no statistical differences) ( Table 4 ). In addition, there was a tendency that the average scores of IM were lower in the gastric type group (0.88 of IM score) than in the intestinal type group (1.44 of IM score, P = 0.095) (6) . Helicobacter pylori infection and severe chronic gastritis with IM are thought to become high risks for differentiated adenocarcinoma in EGC. It has been shown that differentiated adenocarcinoma appears in the mucosa with severe atrophic gastritis and significant IM (1, 22) . In contrast, undifferentiated carcinoma (actually poorly differentiated adenocarcinoma and/ or signet-ring cell carcinoma) arises during progression of atrophic gastritis with Helicobacter pylori infection regardless of IM (18, 22) . Undifferentiated carcinoma is shown to originate not only from IM, but also from the gastric proper mucosa without IM (5) . The relationship between atrophic gastritis and undifferentiated carcinoma has not yet been understood. Therefore, we evaluated the background of gastric mucosa using three evaluation criteria, i.e. mucosal heights, number of glands and score of IM, and discussed the relationship between EGC and atrophic gastric mucosa. As shown our results, the background gastric mucosa with lower IM score was related to the gastric phenotype cancers, and atrophic mucosa with lower mucosal heights was associated with moderately to poorly differentiated adenocarcinoma. We speculated that moderately to poorly differentiated type of EGC originates from the atrophic gastric mucosa with lower mucosal heights and less IM, and has mucin expression of the gastric phenotype. This type of
DISCUSSION
The risk of gastric cancer is related to Helicobacter pylori infection with chronic active inflammation. Previous studies have described the association between EGC and IM. However, relationships between EGC and gastric atrophy are not well understood. In this study, we demonstrated that the cases of moderately to poorly differentiated adenocarcinoma, as well as gastric-type EGC, were more closely associated with atrophy.
The most cases of gastric differentiated adenocarcinoma have been considered to show intestinal phenotypes, and histogenesis of the differentiated adenocarcinoma is related to IM (3, 7, 11) . On the other hand, several papers have reported that some differentiated adenocarcinoma expressed gastric phenotypes (5). In addition, small-sized differentiated adenocarcinoma with gastric mucin expression may develop into large poorly differentiated adenocarcinoma (commonly called undifferentiated carcinoma) during the tumor progression of EGC (3, 10, 13, 16, 21) . These reports indicated that the mucin phenotypes were associated with histopathological differentiation of EGC frequently (9), but not completely. Our results supported this tendency, and showed that 67.9% of moderately to poorly differentiated adenocarcinoma cases were gastric type group, while 64.2% of well differentiated adenocarcinoma cases were intestinal type group. Gastric mucosa is frequently infected with Helicobacter pylori, which cause chronic inflammatory cell infiltration. The persistent inflammatory stimula- EGC is thought to develop to poorly differentiated gastric phenotype (commonly called "undifferentiated carcinoma") in advanced cases (Fig. 3) .
In conclusion, our data suggest that gastric phenotype group cancer and moderately to poorly differentiated adenocarcinoma tended to have background atrophic mucosa with low mucosal heights and less IM. The atrophic gastric mucosa with less IM is thought to play an important role in gastric carcinogenesis, especially tumoriogenesis of gastric phenotype group cancer and moderately to poorly differentiated adenocarcinoma.
